Whole population (N=1593) | Tertile 1, SUA: <5.5Â mg/dL | Tertile 2, SUA: 5.6-7.0Â mg/dL | Tertile 3, SUA: >7.0Â mg/dL | p value |
---|---|---|---|---|
All-cause death, n (%) | 262 (50.3) | 256 (48.9) | 335 (60.9) | <0.001 |
Cardiovascular death, n (%) | 111 (21.3) | 99 (18.9) | 151 (27.5) | 0.003 |
Men (N=897, 56.3%) | Tertile 1, SUA: <5.9Â mg/dL | Tertile 2, SUA: 5.9-7.4Â mg/dL | Tertile 3, SUA: >7.4Â mg/dL | p value |
All-cause death, n (%) | 150 (49.0) | 156 (52.2) | 187 (64.0) | 0.001 |
Cardiovascular death, n (%) | 59 (19.3) | 57 (19.1) | 90 (30.8) | 0.001 |
Women (N=696, 43.7%) | Tertile 1, SUA: <5.1Â mg/dL | Tertile 2, SUA: 5.1-6.5Â mg/dL | Tertile 3, SUA: >6.5Â mg/dL | p value |
All-cause death, n (%) | 101 (45.3) | 122 (51.9) | 137 (57.6) | 0.031 |
Cardiovascular death, n (%) | 46 (20.6) | 52 (22.1) | 57 (23.9) | 0.691 |